Role of catecholamine synthases in the maintenance of cancer stem-like cells in malignant peripheral nerve sheath tumors

Cancer Sci. 2024 Mar;115(3):871-882. doi: 10.1111/cas.16077. Epub 2024 Jan 26.

Abstract

Malignant peripheral nerve sheath tumors (MPNSTs) are malignant tumors that are derived from Schwann cell lineage around peripheral nerves. As in many other cancer types, cancer stem cells (CSCs) have been identified in MPNSTs, and they are considered the cause of treatment resistance, recurrence, and metastasis. As an element defining the cancer stemness of MPNSTs, we previously reported a molecular mechanism by which exogenous adrenaline activates a core cancer stemness factor, YAP/TAZ, through β2 adrenoceptor (ADRB2). In this study, we found that MPNST cells express catecholamine synthases and that these enzymes are essential for maintaining cancer stemness, such as the ability to self-renew and maintain an undifferentiated state. Through gene knockdown and inhibition of these enzymes, we confirmed that catecholamines are indeed synthesized in MPNST cells. The results confirmed that catecholamine synthase knockdown in MPNST cells reduces the activity of YAP/TAZ. These data suggest that a mechanism of YAP/TAZ activation by de novo synthesized adrenaline, as well as exogenous adrenaline, may exist in the maintenance of cancer stemness of MPNST cells. This mechanism not only helps to understand the pathology of MPNST, but could also contribute to the development of therapeutic strategies for MPNST.

Keywords: Schwann cell; benserazide; cancer stem cell; catecholamine synthase; malignant peripheral nerve sheath tumor; vesicular monoamine transporter.

MeSH terms

  • Catecholamines
  • Epinephrine / therapeutic use
  • Humans
  • Nerve Sheath Neoplasms* / pathology
  • Neurofibrosarcoma*
  • Signal Transduction

Substances

  • Catecholamines
  • Epinephrine